环氧化酶-2和CD44v6蛋白在宫颈鳞癌中表达及临床意义

探讨环氧化酶-2(cyclooxy-genase-2,COX-2)和CD44v6蛋白在官颈上皮内瘤样病变(CIN)和浸润宫颈鳞癌(ICC)中的表达及其意义.应用免疫组织化学方法,检测45例ICC、25例CIN和10例正常宫颈组织(NCE)中COX-2和CD44v6蛋白的表达水平,并结合临床病理特征进行分析.结果表明,在ICC、CIN和NCE中,COX-2蛋白表达阳性率分别为82.2%(37/45)、40%(10/25)和0%(0/10),差异有显著性(P＜0.05);CD44v6蛋白表达阳性率分别为88.9%(40/45)、44%(11/25)和20%(2/10),差异有显著性(P＜0.05).COX-2和CD44v6蛋白表达与ICC的分化程度和淋巴结转移相关(P＜0.05),但与临床分期无关(P＞0.05).COX-2和CD44v6可能参与了调控ICC的发生、发展过程,其高表达预示ICC预后不良.     

胚乳性状数量基因的定位方法

将三倍体胚乳性状的数量遗传模型和二倍体性状数量基因（QTL）图构建方法相结合,导出双侧标记基因型下有关胚乳性状QTL的遗传组成、平均数和遗传方差分量,据之提出以某一区间双侧标记基因型胚乳性状的平均值为依变数,以该区间内任一点假定存在的QTL的加性效应d、显性效应h1和／或h2的系数为自变数,进行有重复观察值的多元线性回归分析,根据多元线性回归的显著性测验该点是否存在QTL,并估计出QTL的遗传效应。给定区间内任一点,皆可以此进行分析,从而可在整条染色体上作图,并以之确定QTL的数目和最可能位置,同时,在检测某一区间时,利用多元线性回归方法将该区间外可能存在的QTL的干扰进行统计控制,以提高QTL检测的精度。此外,还讨论了如何将之推广应用于其他类型的DNA不对应资料以及具复杂遗传模型的胚乳性状资料。     

0.5%藜芦碱可溶液剂防治茄子红蜘蛛田间药效初报

藜芦碱可是一种新型植物源农药。通过田间试验对0.5%藜芦碱可溶液剂防治茄子红蜘蛛的效果进行分析。结果表明,0.5%藜芦碱可溶剂300倍液对红蜘蛛有一定的防治效果,初次药后3 d和二次药后5 d的防治效果较低,但末次药后5 d平均防效可达到71.63%。因此,该药剂防治红蜘蛛具有速效性差、持效性好的特点,可用于春季红蜘蛛高发期之前的防治,或与化学药剂交替使用以减轻化学农药对环境和生态的影响。     

福寿螺表型性状的空间尺度变异

格局和尺度是生态学的核心概念。尺度的变化可能导致生态学格局的改变。入侵物种性状的变异会对种群的建立和扩散产生重要的影响。为了研究入侵物种福寿螺(Pomacea canaliculata)表型性状的尺度变异并推测可能的作用机制,在广东省开展了福寿螺的体质量、体高、体宽、壳口宽4个表型性状在城市、乡镇、生境、样方、个体5个空间尺度上变异的研究。通过拟合混合模型,进行方差分解,结果发现个体和样方差异解释了近80%的性状变异,生境的差异解释了除体重外其他性状的剩余变异;除体重外乡镇和城市尺度上性状的变异并不明显。结果进一步表明,区域尺度的过程如气候特征等对福寿螺表型性状变异不起主要作用;福寿螺种群特征的研究及防控的重点应考虑其遗传结构特征及局部尺度环境因素。通过不同尺度下性状的变异系数和频度分布曲线的分析,进一步验证了以上结果。     

蛋白S基因突变及多态性的研究进展

蛋白S在生理抗凝血过程中起着重要的作用.血浆蛋白S水平低下是血栓性疾病发生和发展的危险因素之一.蛋白S基因突变及多态性可增加静脉血栓形成的危险性.本文就蛋白S的理化性质、蛋白S基因突变及多态性,以及与静脉血栓的关系作一综述.     

轻度支气管哮喘儿童的诱导痰菌群特征

目的探讨轻度支气管哮喘儿童的诱导痰菌群特征及临床意义。方法纳入年龄为6~12周岁于2018年11月至2019年1月在深圳市儿童医院呼吸科门诊定期复诊的轻度支气管哮喘患儿51例(哮喘组),留取诱导痰,匹配同年龄段97例健康无过敏儿童的口咽拭子作为对照。诱导痰及口咽拭子提取总DNA并扩增,对16S rRNA基因进行高通量测序并对测序结果进行生物信息学分析。结果NMDS分析结果显示哮喘组与健康对照组研究对象菌群结构存在差异;哮喘组的诱导痰菌群多样性指数(Shannon index)高于健康对照组(2.34±0.53 vs 1.87±0.50,P<0.05)。门水平分析显示,哮喘组与健康对照组的菌群均主要为厚壁菌门(38.34%vs 44.74%,P<0.05)、变形杆菌门(31.14%vs 19.78%,P<0.05)、拟杆菌门(14.59%vs 20.52%,P<0.05)、放线菌门(10.41%vs 7.85%,P<0.05)和梭杆菌门(2.82%vs 6.67%,P<0.05),但两组之间的构成比有明显差异。与健康对照组相比,在属水平上哮喘组韦荣球菌属(5.27%vs 8.96%)、普雷沃菌属(8.38%vs 17.35%)、罗斯菌属(1.50%vs 5.46%)、纤毛菌属(1.37%vs 4.39%)等非条件致病菌属比例明显下降(均P<0.05),而嗜血杆菌属(9.83%vs 6.17%)、卟啉单胞菌属(2.48%vs 1.41%)、莫拉菌属(5.66%vs 0.42%)、诺卡菌属(3.40%vs 0.00%)等条件致病菌属比例明显上升(均P<0.05)。结论尽管轻度支气管哮喘患儿已临床控制,但诱导痰内菌群仍存在结构紊乱。气道菌群紊乱可能是儿童支气管哮喘的发病机制之一。除了致病菌属外,非致病菌菌属的构成变化可能也是儿童哮喘的一个发生机制。     

萘普生降解菌群的驯化及其降解效能

【背景】萘普生是一种被广泛使用的非甾体抗炎药,治疗人类疾病的同时对环境产生一定的消极影响,甚至危害到人类的生存环境。【目的】利用微生物降解萘普生类污染物是一种价格低廉且行之有效的方法。【方法】以萘普生为唯一碳源,培养驯化高效的萘普生降解菌群;利用高通量测序技术解析萘普生降解菌群的微生物群落变化,鉴定萘普生降解菌群种类;通过GC-MS分析萘普生降解菌群的降解途径。【结果】获得了以Rhodanobacter为主的萘普生高效降解菌群,确定了萘普生降解菌群的最佳降解条件为:30°C、pH7.0、摇床转速150r/min、接种量10%,萘普生降解率达60.58%,并预测出萘普生降解菌群的降解途径。【结论】获得了高效的萘普生降解菌群,明晰了降解机理和降解途径,不仅丰富了微生物资源种类,更为微生物的工程应用奠定了理论基础。     

Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis

Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC) for the purpose of developing a miRNA expression signature to determine the risk of metastasis and prognosis. We used the microarray technology to profile miRNA expression of 78 benign kidney and ccRCC samples. Using 28 localized and metastatic ccRCC specimens as the training cohort and the univariate logistic regression and risk score methods, we developed a miRNA signature model in which the expression levels of miR-10b, miR-139-5p, miR-130b and miR-199b-5p were used to determine the status of ccRCC metastasis. We validated the signature in an independent 40-sample testing cohort of different stages of primary ccRCCs using the microarray data. Within the testing cohort patients who had at least 5 years follow-up if no metastasis developed, the signature showed a high sensitivity and specificity. The risk status was proven to be associated with the cancer-specific survival. Using the most stably expressed miRNA among benign and tumorous kidney tissue as the internal reference for normalization, we successfully converted his signature to be a quantitative PCR (qPCR)-based assay, which showed the same high sensitivity and specificity. The 4-miRNA is associated with ccRCC metastasis and prognosis. The signature is ready for and will benefit from further large clinical cohort validation and has the potential for clinical application.     

Proteolysis of the Human DNA Polymerase Delta Smallest Subunit p12 by μ-Calpain in Calcium-Triggered Apoptotic HeLa Cells

Degradation of p12 subunit of human DNA polymerase delta (Pol δ) that results in an interconversion between Pol δ4 and Pol δ3 forms plays a significant role in response to replication stress or genotoxic agents triggered DNA damage. Also, the p12 is readily degraded by human calpain in vitro. However, little has been done for the investigation of its degree of participation in any of the more common apoptosis. Here, we first report that the p12 subunit is a substrate of μ-calpain. In calcium-triggered apoptotic HeLa cells, the p12 is degraded at 12 hours post-induction (hpi), restored thereafter by 24 hpi, and then depleted again after 36 hpi in a time-dependent manner while the other three subunits are not affected. It suggests a dual function of Pol δ by its interconversion between Pol δ4 and Pol δ3 that is involved in a novel unknown apoptosis mechanism. The proteolysis of p12 could be efficiently blocked by both calpain inhibitor ALLN and proteasome inhibitor MG132. In vitro pull down and co-immunoprecipitation assays show that the μ-calpain binds to p12 through the interaction of μ-calpain with Pol δ other three subunits, not p12 itself, and PCNA, implying that the proteolysis of p12 by μ-calpain might be through a Pol δ4/PCNA complex. The p12 cleavage sites by μ-calpain are further determined as the location within a 16-amino acids peptide 28-43 by in vitro cleavage assays. Thus, the p12/Pol δ is a target as a nuclear substrate of μ-calpain in a calcium-triggered apoptosis and appears to be a potential marker in the study of the chemotherapy of cancer therapies.